Search PubMed⌕ Search

Biomedical subjects

D W Anderson

Publications and source records attributed to D W Anderson.

At least 127 records · Page 7Linked to original sources

Evans blue dye adjuvant enhances delayed hypersensitivity while blocking immunity to Mycobacterium tuberculosis in mice.

Evans blue dye functions as an adjuvant with protein antigens in saline to induce cell-mediated immunological responses in mice. But when used to help induce cell-mediated tuberculoimmunity, it decreased mouse resistance to tuberculosis instead of helping induce immunity. This paradox was investigated. As could be expected from previous work with other antigens, the dye did promote induction of delayed hypersensitivity in mice to tuberculoprotein when injected in saline with killed tubercle bacilli. Peritoneal macrophages from mice injected with the dye responded normally to migration inhibition factor. Morphologically, these cells were moderately "activated" compared with similar cells taken from untreated mice. However, such cells incubated with tuberculosis growth inhibition lymphokine in an in vitro test for tuberculoimmunity did not express tuberculoimmunity, whereas macrophages from untreated mice did. Therefore, Evans blue dye did promote induction of cell-mediated immunological responses and tuberculoimmunity in lymphocytes, but under the conditions used in these experiments, it also blocked expression of tuberculoimmunity by macrophages.

Adjuvants, Immunologic↗

Transport of apolipoproteins A-I and A-II by human thoracic duct lymph.

The daily transport of human plasma apolipoproteins A-I and A-II, triglyceride, and total cholesterol from the thoracic duct lymph into plasma was measured in two subjects before and three subjects after renal transplantation. Lymph triglyceride transport was approximately 83% of the daily ingested fat loads, whereas lymph cholesterol transport was consistently greater than the amount of daily ingested cholesterol. Lymph apolipoprotein transport significantly (P < 0.05) exceeded the predicted apolipoprotein synthesis rate by an average of 659+/-578 mg/d for apolipoprotein A-I and 109+/-59 mg/d for apolipoprotein A-II among the five subjects. It is estimated that 22-77% (apolipoprotein A-I) and 28-82% (apolipoprotein A-II) of daily total body apolipoprotein synthesis takes place in the intestine. Lymph high density lipoprotein particles are mostly high density lipoprotein(2b) and high density lipoprotein(2a) and have a greater overall relative triglyceride content and a smaller relative cholesteryl ester content when compared with homologous plasma high density lipoproteins. The major quantity of both lymph apolipoprotein A-I (81+/-8%) and apolipoprotein A-II (90+/-11%) was found within high density lipoproteins with almost all of the remainder found in chylomicrons and very low density lipoproteins. The combined results are consistent with a major contribution of the intestine to total body synthesis of apolipoprotein A-I and apolipoprotein A-II. An important role of lymph in returning filtered apolipoprotein to plasma in association with high density lipoproteins is proposed. Accompanying the return of filtered apolipoprotein to the plasma is a probable transformation, both in size and composition, of at least some of the lymph high density lipoprotein(2b) and high density lipoprotein(2a) particles into high density lipoprotein(3).

Apolipoproteins↗

An acute lymphoblastic leukemia which produces human T cell growth factor.

We report the production of T cell growth factor activity by a PHA stimulated acute lymphoblastic leukemia cell line designated HSB-2. Factor production was enhanced by the addition of phorbol myristate acetate to the cultures. The growth factor will enhance the proliferation of PHA stimulated thymocytes and sustain the proliferation of growth-factor dependent human T cell blasts. The characteristics of the cell line are described.

B-Lymphocytes↗

Metabolism of high density lipoprotein subfractions and constituents in Tangier disease following the infusion of high density lipoproteins.

The metabolism of apolipoproteins A-I and A-II, as well as other high density lipoprotein (HDL) constituents, was studied in patients with homozygous familial HDL deficiency (Tangier disease) prior to and after plasma exchange or HDL infusion. Mean plasma apoA-I, apoA-II, and HDL cholesterol values in homozygotes (n = 2) were 2.0 mg/dl, 2.7 mg/dl, and 1.5 mg/dl, respectively, and in a normal control subject were 125.1 mg/dl, 23.0 mg/dl, and 53.0 mg/dl, respectively. Based on radioiodinated apoA-I and apoA-II kinetic studies in the baseline state, synthesis rates for apoA-I and apoA-II in mg/kg/day were 3.81 and 1.61, respectively, in one homozygote (patient B) and 11.82 and 1.99, respectively, in the normal subject. ApoA-I and apoA-II plasma residence times in days were 0.22 and 0.81, respectively, in the homozygote, and 4.04 and 4.44, respectively, in the normal subject. These data indicate that this homozygote had both a moderate decrease in the synthetic rates of apoA-I and apoA-II, as well as a marked decrease in the plasma residence times of these two apolipoproteins. In one homozygote (patient A) following a complete plasma exchange during cardiopulmonary bypass, plasma HDL cholesterol, apoA-I, and apoA-II levels were very similar to pre-exchange values within 64 hr after exchange. A second homozygote (patient B) received HDL intravenously as well as 125I-labeled apoA-I and 131I-labeled apoA-II. Following infusion, the residence time in days for HDL subfractions, HDL2b, HDL2a, and HDL3 were 0.1, 0.8, and 2.7, respectively. HDL protein and phospholipid both had a monoexponential decay, with residence times of 0.7 days, while HDL triglyceride disappeared monoexponentially with a residence time of 0.5 days. HDL cholesterol had a biexponential decay, with the residence time of the slow component being 0.7 days. Plasma and HDL apoA-I decayed down to baseline values significantly faster than did plasma and HDL apoA-II. ApoA-II specific radioactivity decreased throughout the course of the infusion study in both plasma and HDL, while apoA-I specific radioactivity decreased slightly, then rose, and subsequently declined in both plasma and HDL. The data indicate that the rapid and altered catabolism of apoA-I and apoA-II in Tangier homozygotes persists despite major increases in the plasma pool size of these proteins. In addition, following HDL infusion, HDL2b and HDL2a disappeared at a faster rate than HDL3, HDL cholesterol and triglyceride were catabolized at a faster rate than HDL protein and phospholipid, and apoA-I disappeared more rapidly than apoA-II. These observations may have important implications with regard to the catabolism of HDL subfractions and constituents in normal man.

Adult↗

The National Head and Spinal Cord Injury Survey: design and methodology.

The National Head and Spinal Cord Injury Survey was designed to provide statistics that measure the morbidity and economic costs of injury to the head or spinal cord for the population in the contiguous United States for the year 1974. This article described the multistage design that was used for sampling in the survey, and includes general remarks on random and probability sampling. The criteria for eligibility for the survey and the methodology for data collection are also discussed. It is necessary to understand these aspects of the survey in order to interpret the findings.

Craniocerebral Trauma↗

The National Head and Spinal Cord Injury Survey: assessment of some uncertainties affecting the findings.

The estimates from the National Head and Spinal Cord Injury Survey, like estimates from other studies, are subject to many uncertainties and must be viewed as conditional. This article provides a list of conditions that affect estimates from studies. For this survey, two structural limitations are discussed. The first is the exclusion from the survey of persons who were fatally injured and did not receive hospital inpatient care (for instance, individuals who were dead on arrival at the hospital). The second is the exclusion from the survey of persons who were injured before 1970. Also, uncertainties in the data of the survey due to nonresponse and variability between data collectors are discussed.

Craniocerebral Trauma↗

Scattered radiation from trimmer bars in the cobalt-60 teletherapy machines.

The amount of scattered radiation resulting from four Cobalt-60 teletherapy units in four different hospitals when trimmer bars were fully extended was studied. Scatter was present for all machines checked at between 10% and 20% of the central axis dose. Clinical significance is also discussed.

Cobalt Radioisotopes↗

Plasma-triglycerides in regulation of H.D.L.-cholesterol levels.

Plasma-high-density-lipoprotein (H.D.L.) cholesterol concentrations are lower in patients with coronary-artery disease than in control subjects. In an investigation of the relationship of H.D.L. cholesterol to other lipid and lipoprotein parameters in normal and hyperlipoproteinaemic subjects inverse correlations were found between H.D.L. cholesterol and very-low-density-lipoprotein (V.L.D.L.) cholesterol, and between H.D.L. cholesterol and plasma-triglyceride levels. Mean H.D.L.-cholesterol concentrations in normal subjects were 50 mg/dl, and in hyperlipoproteinaemic patients they were: type I, 17 mg/dl; type II, 44 mg/dl; type III, 38 mg/dl; type IV, 37 mg/dl; and type V, 27 mg/dl. H.D.L.-cholesterol levels were lowest in patients with fasting chylomicronaemia and were diminished in hypertriglyceridaemic subjects, suggesting a relationship between the metabolism of triglyceride-rich lipoproteins and H.D.L.

Cholesterol↗